LGALS3 and type 1 diabetes mellitus: Together, these findings suggest that elevated serum Galectin-3 in T1D may result from increased intestinal permeability and subsequent LPS-driven activation of monocytes/macrophages, underscoring the potential of Galectin-3 to serve as a biomarker for preclinical autoimmune diabetes.